West Virginia 2022 Regular Session

West Virginia House Bill HB2817

Introduced
1/12/22  
Refer
1/12/22  
Engrossed
1/31/22  
Refer
2/1/22  
Refer
2/1/22  
Report Pass
3/2/22  
Enrolled
3/11/22  
Passed
3/12/22  

Caption

Donated Drug Repository Program

Impact

This legislation amends the Code of West Virginia, allowing the West Virginia Board of Pharmacy to administer the program. It sets forth clear definitions, eligibility requirements for donors and recipients, and outlines the responsibilities of all parties involved. Notably, eligibility for received drugs extends beyond indigent individuals to include any person in need if surplus medication exists. The inclusion of liability protections for donors and recipients is intended to encourage participation in the program without fear of repercussions should issues arise from medication quality or patient care.

Summary

House Bill 2817 establishes the Donated Drug Repository Program in West Virginia, creating a framework for the donation and dispensation of drugs to indigent patients. This program aims to enhance access to necessary medications for individuals in need by facilitating the donation of both prescription and over-the-counter drugs from eligible donors, which include pharmacies, healthcare professionals, and various health service entities. By streamlining the process, the bill intends to maximize the utility of surplus medications while ensuring patient safety and compliance with health regulations.

Sentiment

Generally, the sentiment surrounding HB 2817 is positive, reflecting support for increasing access to essential health care products for low-income populations. Proponents argue that the bill not only helps mitigate drug waste but also aligns with broader efforts to improve public health outcomes. However, some concerns were mentioned regarding the safety protocols in place and ensuring that donated drugs are handled properly to avoid risks associated with improper use.

Contention

Points of contention mainly revolve around ensuring the safety and efficacy of donated drugs as well as the program's implementation specifics. Critics worry about the potential ramifications of having non-regulated medications dispensed to patients, citing the need for stringent oversight and quality assurance processes. Additionally, there may be discussions about what constitutes an appropriate handling fee, and how it could affect the very individuals the program seeks to assist.

Companion Bills

No companion bills found.

Similar Bills

MA H1374

Establishing a state-wide drug repository program

MA H1208

Establishing a state-wide drug repository program

TN SB0675

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63 and Title 68, relative to a prescription drug donation repository program.

TN HB0667

AN ACT to amend Tennessee Code Annotated, Title 56; Title 63 and Title 68, relative to a prescription drug donation repository program.

CO SB061

Creating a Drug Donation Program

AZ SB1377

Authorized recipients; donated medicine; information

CA SB1346

Surplus medication collection and distribution.

CO SB289

Creation of a Drug Donation Program